JUN and carcinoma: An additional RMC-7977-resistant tumour exhibited a focal gain in Jun, a canonical member of the AP1 transcription factor complex that acts downstream of the RAS–MAPK pathway to drive proliferation (Extended Data Fig. 6a)—Jun copy number gains have rarely been reported in PDAC or other carcinomas.